On Friday, Cidara Therapeutics Inc (NASDAQ: CDTX) was 6.77% up from the session before settling in for the closing price of $84.76. A 52-week range for CDTX has been $10.14 – $90.64.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 1.30%. When this article was written, the company’s average yearly earnings per share was at 77.20%. With a float of $19.37 million, this company’s outstanding shares have now reached $23.23 million.
Cidara Therapeutics Inc (CDTX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cidara Therapeutics Inc stocks. The insider ownership of Cidara Therapeutics Inc is 23.61%, while institutional ownership is 84.29%. The most recent insider transaction that took place on Sep 11 ’25, was worth 29,797. In this transaction Chief Medical Officer of this company sold 474 shares at a rate of $62.86, taking the stock ownership to the 31,418 shares. Before that another transaction happened on Jun 26 ’25, when Company’s Director bought 2,272,727 for $44.00, making the entire transaction worth $99,999,988. This insider now owns 3,365,523 shares in total.
Cidara Therapeutics Inc (CDTX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -2.38 earnings per share (EPS) during the time that was better than consensus figure (set at -5.44) by 3.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 77.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.92% during the next five years compared to 1.30% growth over the previous five years of trading.
Cidara Therapeutics Inc (NASDAQ: CDTX) Trading Performance Indicators
You can see what Cidara Therapeutics Inc (CDTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 16.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.14, a number that is poised to hit -1.39 in the next quarter and is forecasted to reach -7.76 in one year’s time.
Technical Analysis of Cidara Therapeutics Inc (CDTX)
The latest stats from [Cidara Therapeutics Inc, CDTX] show that its last 5-days average volume of 1.65 million was superior to 0.44 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 89.73%.
During the past 100 days, Cidara Therapeutics Inc’s (CDTX) raw stochastic average was set at 99.51%, which indicates a significant increase from 98.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 5.26 in the past 14 days, which was higher than the 3.47 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $65.62, while its 200-day Moving Average is $35.42. Now, the first resistance to watch is $93.20. This is followed by the second major resistance level at $95.90. The third major resistance level sits at $100.96. If the price goes on to break the first support level at $85.44, it is likely to go to the next support level at $80.38. Assuming the price breaks the second support level, the third support level stands at $77.68.
Cidara Therapeutics Inc (NASDAQ: CDTX) Key Stats
There are 25,358K outstanding shares of the company, which has a market capitalization of 2.29 billion. As of now, sales total 1,280 K while income totals -169,830 K. Its latest quarter income was 0 K while its last quarter net income were -25,720 K.
